Compare GDDY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDDY | ICLR |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.3B |
| IPO Year | 2014 | 2001 |
| Metric | GDDY | ICLR |
|---|---|---|
| Price | $95.39 | $162.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $136.44 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 2.1M | 819.6K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $6.10 | N/A |
| P/E Ratio | $29.30 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.59 | $66.57 |
| 52 Week High | $148.51 | $203.91 |
| Indicator | GDDY | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 47.77 |
| Support Level | $82.87 | $162.06 |
| Resistance Level | $106.00 | $188.49 |
| Average True Range (ATR) | 4.87 | 7.15 |
| MACD | 0.12 | -0.72 |
| Stochastic Oscillator | 68.91 | 32.80 |
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.